pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 21·1 min read
save

Urologist warns that Defense Dept's testosterone screening for servicemembers fuels outdated masculinity myths

Jul 21, 2026·read at STAT ↗Negative

Dr. Elizabeth Dray, a urologist, criticizes Defense Secretary Pete Hegseth's recent plan to screen all service members aged 30 and older for testosterone, describing it as a modern echo of ancient masculine ideals.

She argues that the belief higher testosterone makes men braver is a myth, noting that hormone levels do not determine courage or battlefield performance.

Dray contrasts the ancient Greek notion of masculinity-centered on courageous sacrifice-with today's fantasy of an optimized soldier, warning the policy could become a tragedy.

While acknowledging testosterone influences many bodily functions, she urges a more nuanced view of health that separates hormone metrics from notions of bravery.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: Pete Hegseth, ‘The Odyssey,’ and the testosterone myth”

read at STAT ↗
1,352 words · retrieved Jul 21
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
RISING
drugs
Bio T14Testim14Vogelxo14testosterone14
topics
Endocrinology & Metabolism2Ophthalmology2Orthopedics

related stories

  • Dec 22Fierce Biotech Fundraising Tracker '26: AusperBio adds $120M; Abcuro secures $66MFierce Biotech
  • Jul 22Job dissatisfaction and health care access uncertainty grows in the U.S., new study findsSTAT
  • Jun 4Male puberty is understudied — but when it starts may predict long-term health risksSTAT
  • Jul 20Opinion: It’s time to treat pandemics as threats to national securitySTAT
  • Jul 18Opinion: Beware the unintended consequences of testosterone screening for military servicemembersSTAT